Significant progress in understanding the pathophysiology of AD has been made using mouse models incorporating familial mutations in amyloid precursor protein (APP) and/or presenilin‐1 (PSEN1), originally designed to recapitulate the cognitive symptoms of AD. This evidence concerns the gene PSEN1 and Alzheimer disease.